32 results
Thumbnail

D3.51 - Cardiovascular System Problems in Children Athletes with Allergic Diseases

Thumbnail

D3.53 - Prevalence of allergic sensitization to edible insects in exposed breeders from Thailand

Thumbnail

D3.59 - Occupational Cobalt Contact Dermatitis: Clinical Profile and Work implications

Thumbnail

D3.52 - Clinical spectrum and diagnostic challenges of paediatric angioedema without wheals

Thumbnail

D3.55 - Hereditary angioedema with normal C1-INH: DAB2IP mutation report

Thumbnail

D3.56 - Investigation of Serum Eosinophilic Granule Proteins Levels in Children with Chronic Spontaneous Urticaria

Thumbnail

D3.57 - Respiratory Manifestations Of Ascariasis Mimicking Allergic Disease: A Clinical Case

Thumbnail

D3.58 - Eosinophilic ascites and extreme hypereosinophilia: differential diagnosis through medical treatment

Thumbnail

D3.60 - Allergic reaction in bisoprolol overdose

Thumbnail

D3.61 - Acquired Food Allergy After Allogeneic Hematopoietic Stem Cell Transplantation From a Non-Allergic Unrelated Donor

Thumbnail

D3.62 - Application of a logistic regression model to predict the risk of allergic reactions in children with salmon sensitization (Sal s 1)

Thumbnail

D3.49 - Associations between the prevalence of sensitization of pets and symptoms of allergic rhinitis (AR) in children

Thumbnail

D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort